This NICE technology appraisal guidance on ezetimibe for primary (heterozygous-familial and non-familial) hypercholesterolaemia should be read in conjunction with the NICE technology appraisal guidance on the initiation of statin therapy (Technology Appraisal 94) and in the context of the relevant NICE clinical guidelines.The full guidance 1 was published in the NICE technology appraisal guidance in November 2007. The guidance was developed using NICE's multiple technology appraisal process. Further information is available in the Guide to the methods of technology appraisal. 2
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.